Exact Sciences, a provider of cancer screening and diagnostic tests, agreed to acquire Resolution Bioscience, a cancer diagnostics solutions provider, from Agilent Technologies, an American analytical instrumentation development and manufacturing company. Financial terms were not disclosed. "We are excited to work with the Resolution Bioscience team to integrate their innovative diagnostics into our Precision Oncology portfolio. Resolution Bioscience's high-quality liquid therapy selection platform perfectly complements our OncoExTra test, allowing Exact Sciences to help more cancer patients determine their best treatment options," Brian Baranick, Exact Sciences general manager of Precision Oncology.